Henderson Group
http://www.henderson.comHenderson Group, the holding company for Henderson Global Investors, is a global asset management firm based in London, England. The firm invests in a broad range of asset classes including equities, fixed income, property, and private capital for its institutional, retail and high net-worth clients.
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A Akero Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Metsera, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A SENSIENT TECHNOLOGIES Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A AVADEL PHARMACEUTICALS Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: JANUS HENDERSON GROUP PLC
-
Form 13F-HR JANUS HENDERSON GROUP For: Dec 31
-
Form 4 JANUS HENDERSON GROUP For: Feb 11 Filed by: THOMPSON ROGER MJ
-
Janus Henderson Affiliates Privacore Capital and Victory Park Capital Launch First Interval Fund focused on Private Asset-Backed Credit
-
Form SCHEDULE 13G/A Biohaven Ltd. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Equillium, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form 4 JANUS HENDERSON GROUP For: Feb 03 Filed by: ROSENBERG MICHELLE
-
Form 4 JANUS HENDERSON GROUP For: Feb 02 Filed by: Dibadj Ali
-
Form SC 13E3 JANUS HENDERSON GROUP Filed by: JANUS HENDERSON GROUP PLC
-
Form PREM14A JANUS HENDERSON GROUP For: Jan 30
-
Janus Henderson Group plc (JHG) Tops Q4 EPS by 86c
-
Janus Henderson Group plc Reports Fourth Quarter and Full-Year 2025 Results
-
Form 8-K JANUS HENDERSON GROUP For: Jan 30
-
Janus Henderson to acquire Richard Bernstein Advisors for $20 billion assets
-
Janus Henderson Announces Acquisition of Richard Bernstein Advisors
-
Janus Henderson to Report Fourth Quarter and Full-Year 2025 Results
-
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Camp4 Therapeutics Corp Filed by: JANUS HENDERSON GROUP PLC
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Flushing Financial Corp. (Nasdaq - FFIC), FONAR Corporation (Nasdaq - FONR), Clearwater Analytics Holdings, Inc
-
Form 3 JANUS HENDERSON GROUP For: Dec 21 Filed by: MASSACHUSETTS MUTUAL LIFE INSURANCE CO
-
Form DEFA14A JANUS HENDERSON GROUP
-
Form SCHEDULE 13D JANUS HENDERSON GROUP Filed by: MASSACHUSETTS MUTUAL LIFE INSURANCE CO
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Clearwater Analytics Holdings, Inc. (NYSE - CWAN), Katapult Holdings, Inc. (Nasdaq - KPLT), Janus Henderson Gro
-
Form SCHEDULE 13D/A JANUS HENDERSON GROUP Filed by: TRIAN FUND MANAGEMENT, L.P.
-
Form DEFA14A JANUS HENDERSON GROUP
-
Form DEFA14A JANUS HENDERSON GROUP
-
Form DEFA14A JANUS HENDERSON GROUP
-
Trian, General Catalyst to buy Janus Henderson for $7.4 billion
-
Form DEFA14A JANUS HENDERSON GROUP
-
Form 8-K JANUS HENDERSON GROUP For: Dec 21
-
Janus Henderson agrees to $7.4 billion acquisition by Trian and General Catalyst
-
Trian and General Catalyst to acquire Janus Henderson for $7.4 billion
-
Janus Henderson Group plc to be Acquired by Trian Fund Management and General Catalyst for $7.4 Billion
-
John M. Cassaday Joins Rival Group Board of Directors
-
Victory Park Capital Announces New Warehouse Facility with Zip, Expanding Long-Standing Partnership
-
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G PALATIN TECHNOLOGIES Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G PALISADE BIO, INC. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Pasithea Therapeutics Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Ocugen, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G DBV Technologies S.A. Filed by: JANUS HENDERSON GROUP PLC

